CWBHF

0.17500.17%
MB

Marcel Bonn-Miller

Chief Scientific Officer

Dr. Marcel Bonn-Miller is Member of Scientific Advisory Board of AJNA BioSciences PBC. Dr. Marcel, PhD, is Chief Scientific Officer at Charlotte's Web Holdings, Inc. since joining from March 2023. Prior to joining Charlotte's Web, he served few years at Canopy Growth Corporation, most recently as Vice- President of Human and Animal Research. He had been Director of Cannabinoid Research at Zynerba Pharmaceuticals, Inc. since December 12, 2016. Dr. Bonn-Miller has been an Adjunct Assistant Professor in the Department of Psychiatry at the University of Pennsylvania Perelman School of Medicine. He was a Research Health Science Specialist at the Center of Excellence in Substance Abuse Treatment and Education at the Philadelphia Veterans Affairs Medical Center in Philadelphia, PA, as well as at the National Center for PTSD, Dissemination and Training Division and Center for Innovation to Implementation at the Veterans Affairs Palo Alto Health Care System in Menlo Park, CA. He served as Executive Director at the Institute for Research on Cannabinoids (IROC) in Colorado Springs, Co. Dr. Bonn-Miller earned a BA in psychology and PhD in clinical psychology from the University of Vermont. Dr. Bonn-Miller has published several research papers on cannabinoid science and co-authored three patents related to the use of cannabidiol (CBD) in the treatment of psychological illnesses. Additionally, he has formally reviewed a significant number of medical articles and books on cannabinoids, addiction and behavioral psychology and serves on the editorial boards of a number of scientific journals. Dr. Bonn-Miller has received numerous research grants and awards of recognition for his research, including Researcher of the Year by Americans for Safe Access. He holds a Doctor of Philosophy (Ph.D.) in Clinical Psychology from the University of Vermont and was a postdoctoral fellow in the Center for Health Care Evaluation at the Veterans Affairs Palo Alto Health Care System & Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. He is a member of the International Cannabinoid Research Society (ICRS), American Psychological Association (APA) and College of Problems on Drug Dependence (CPDD). He served as the Non-Executive Director at AusCann Group Holdings Ltd since September 05, 2019 until October 3, 2020. Dr. Bonn-Miller is a Global Clinical Scientific Director of Spectrum Therapeutics, the medical division of Canopy Growth Corporation, with extensive world-class experience in cannabinoids research, pharmaceutical development and clinical trials worldwide. Dr. Bonn-Miller is a worldrenowned researcher and pharmaceutical executive, bringing extensive clinical research and development expertise in cannabinoid-products for medical use. He has received funding for 27 research grants, has published 140 peerreviewed academic papers and has led or contributed to 19 clinical trials.

Positions